JP2006516251A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516251A5 JP2006516251A5 JP2004563903A JP2004563903A JP2006516251A5 JP 2006516251 A5 JP2006516251 A5 JP 2006516251A5 JP 2004563903 A JP2004563903 A JP 2004563903A JP 2004563903 A JP2004563903 A JP 2004563903A JP 2006516251 A5 JP2006516251 A5 JP 2006516251A5
- Authority
- JP
- Japan
- Prior art keywords
- propoxy
- indanyl
- acetic acid
- thiazol
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43531002P | 2002-12-20 | 2002-12-20 | |
| US60/435,310 | 2002-12-20 | ||
| PCT/US2003/040842 WO2004058174A2 (en) | 2002-12-20 | 2003-12-19 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006516251A JP2006516251A (ja) | 2006-06-29 |
| JP2006516251A5 true JP2006516251A5 (US07476746-20090113-C00133.png) | 2007-02-15 |
| JP4974463B2 JP4974463B2 (ja) | 2012-07-11 |
Family
ID=32682216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563903A Expired - Fee Related JP4974463B2 (ja) | 2002-12-20 | 2003-12-19 | インダン酢酸誘導体ならびに製薬学的薬剤としてのそれらの使用、中間体及び製造方法 |
Country Status (7)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110010824A (ko) | 2003-01-14 | 2011-02-07 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서의 １,２,３-삼치환된 아릴 및 헤테로아릴 유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된 장애의 예방 및 치료 |
| ATE339205T1 (de) * | 2003-04-17 | 2006-10-15 | Kalypsys Inc | (3-ä3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl pyrimidin-2-yl)-amino)-propoxyü-phenyl)- essigsäure und verwandte verbindungen als modulatoren von ppars und verfahren zur behandlung von stoffwechselstörungen |
| JP4805552B2 (ja) * | 2003-05-30 | 2011-11-02 | 武田薬品工業株式会社 | 縮合環化合物 |
| CA2527691C (en) | 2003-05-30 | 2013-01-22 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| JP4920410B2 (ja) | 2003-07-14 | 2012-04-18 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 代謝モジュレーターとしての縮合アリールおよびヘテロアリール誘導体ならびに代謝に関連する障害の予防および治療 |
| UA84035C2 (ru) * | 2003-10-31 | 2008-09-10 | Янссен Фармацевтика Н.В. | Производные феноксиуксусных кислот, полезные как двойные агонисты активированных рецепторов пероксисомального пролифератора (ppar) |
| CA2545048A1 (en) * | 2003-11-20 | 2005-06-02 | Warner-Lambert Company Llc | Androgen receptor modulators |
| US7622491B2 (en) * | 2004-08-13 | 2009-11-24 | Metabolex Inc. | Modulators of PPAR and methods of their preparation |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| EP1849465A4 (en) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | AGENT FOR CONTROLLING THE FUNCTION OF THE GPR34 RECEPTOR |
| US7790720B2 (en) * | 2005-03-31 | 2010-09-07 | Ucb Pharma, S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| US7816536B2 (en) | 2005-06-10 | 2010-10-19 | The Research Foundation Of State University Of New York | 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same |
| JP4999923B2 (ja) | 2006-06-13 | 2012-08-15 | 中国科学院上海薬物研究所 | 複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物 |
| TW200936130A (en) * | 2008-02-26 | 2009-09-01 | Lundbeck & Co As H | Uses of indane compounds |
| EP2389226B1 (en) | 2009-01-23 | 2013-11-20 | Merck Sharp & Dohme Corp. | Bridged and fused heterocyclic antidiabetic compounds |
| CA2749891A1 (en) | 2009-01-23 | 2010-07-29 | Hubert B. Josien | Bridged and fused antidiabetic compounds |
| WO2010091176A1 (en) | 2009-02-05 | 2010-08-12 | Schering Corporation | Phthalazine-containing antidiabetic compounds |
| US20120141483A1 (en) * | 2009-06-04 | 2012-06-07 | Mary Katherine Delmedico | Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives |
| JP2012188352A (ja) * | 2009-07-13 | 2012-10-04 | Dainippon Sumitomo Pharma Co Ltd | ３−（４−置換アルキル−フェニル）−２−フランカルボン酸誘導体およびその薬学的に許容される塩 |
| US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| WO2012074980A2 (en) * | 2010-12-01 | 2012-06-07 | Dara Biosciences, Inc. | Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives |
| MX2021011472A (es) | 2015-01-06 | 2022-08-17 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
| KR102603199B1 (ko) | 2015-06-22 | 2023-11-16 | 아레나 파마슈티칼스, 인크. | Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염 |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6197241A (ja) * | 1984-10-16 | 1986-05-15 | Yamanouchi Pharmaceut Co Ltd | 新規カルボン酸誘導体 |
| CA1314224C (en) * | 1987-07-07 | 1993-03-09 | Shinichiro Ashida | Antidiabetic agent |
| AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
| UA79755C2 (en) | 2002-04-16 | 2007-07-25 | Bayer Pharmaceuticals Corp | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
-
2003
- 2003-12-19 WO PCT/US2003/040842 patent/WO2004058174A2/en active Application Filing
- 2003-12-19 CA CA002510793A patent/CA2510793A1/en not_active Abandoned
- 2003-12-19 US US10/537,630 patent/US7714004B2/en not_active Expired - Fee Related
- 2003-12-19 DE DE60336264T patent/DE60336264D1/de not_active Expired - Lifetime
- 2003-12-19 EP EP03800063A patent/EP1578715B1/en not_active Expired - Fee Related
- 2003-12-19 JP JP2004563903A patent/JP4974463B2/ja not_active Expired - Fee Related
- 2003-12-19 AU AU2003299790A patent/AU2003299790A1/en not_active Abandoned
-
2010
- 2010-04-13 US US12/759,328 patent/US7906653B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006516251A5 (US07476746-20090113-C00133.png) | ||
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| RU2419624C2 (ru) | Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2 | |
| RU2203897C2 (ru) | Производные бензамидина, способ их получения, фармацевтическая композиция, способ ее получения и лекарственное средство | |
| JP5261383B2 (ja) | ヒトプロテインチロシンホスファターゼ阻害剤および使用法 | |
| JP2010519181A5 (US07476746-20090113-C00133.png) | ||
| AU754488B2 (en) | Method for treating diabetes employing an aP2 inhibitor and combination | |
| JP2009542717A5 (US07476746-20090113-C00133.png) | ||
| KR940019699A (ko) | 옥사졸리딘디온 유도체, 그의 제조방법 및 용도 | |
| JP2020516671A5 (US07476746-20090113-C00133.png) | ||
| JP2004534035A5 (US07476746-20090113-C00133.png) | ||
| JP2009530281A5 (US07476746-20090113-C00133.png) | ||
| RU2003112691A (ru) | Бензамидные соединения в качестве ингибиторов секреции аро в | |
| RU2006134004A (ru) | Производные гетероариламинопиразола, пригодные для лечения диабета | |
| KR960704544A (ko) | 비인슐린 의존성 당뇨병(niddm)의 개시를 예방 또는 지체시키기 위한 티아졸리딘디온의 용도[use of thiazolidinediones to prevent or delay onset of niddm] | |
| RU2004122407A (ru) | Амидные производные в качестве активаторов gk | |
| JP2007504160A5 (US07476746-20090113-C00133.png) | ||
| CA2486399A1 (en) | Calcium receptor modulating agents | |
| CA2583217A1 (en) | 1,3,4-thiadiazole compounds as protein kinase inhibitors | |
| JP2006077019A5 (US07476746-20090113-C00133.png) | ||
| JP2005526696A5 (US07476746-20090113-C00133.png) | ||
| JP2014528450A5 (US07476746-20090113-C00133.png) | ||
| JP2009501776A5 (US07476746-20090113-C00133.png) | ||
| JP2014523400A5 (US07476746-20090113-C00133.png) | ||
| JP2018507234A5 (US07476746-20090113-C00133.png) |
